Issue 1 covers false alarms, broad sequencing and what AI agents mean for biosecurity.
BioRadar has published the first issue of Baseline, a monthly newsletter for public health and emergency-management leaders on how early warning for biological threats works and what to ask of it. Issue 1 went out Oct. 1 and is now available on the BioRadar website.
Inside:
- The Readout. Co-founder and CEO Ashish Jha on why surveillance that counts cases shows where an outbreak has been, and why decision-makers need visibility into what’s coming.
- Worth Asking. Three questions to put to whoever runs your current surveillance. Does an alert rest on one signal or several? What is the false-positive rate, and how is it measured? When sources disagree, who decides?
- The Mechanism. Why broad metagenomic sequencing is now practical as a standing capability, and why that makes signal detection the hard part. One stream is a hypothesis. Convergence across independent streams is a signal.
- Founder POV. Co-founder and President Nikki Romanik on why autonomous AI agents remove the human pause that screening depends on.
The issue also announces the co-chairs of BioRadar’s new Scientific Advisory Board, Dr. David Relman of Stanford and Dr. Kevin Esvelt of MIT, and Ambika Bumb, PhD, as chief business officer.
New issues publish monthly. Read Issue 1 | Browse the archive | Subscribe